Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Aapro

Showing results (31-40 of 138) with videos related to

Pageof 14
Sort By:
Critical Reviews in Oncology/Hematology|May 8, 1998
Screening and chemopreventionL Repetto, C Granetto, A Venturino, et al.
Cancer Treatment Reviews|September 19, 2009
Management of primary and advanced breast cancer in older unfit patients (medical treatment)M Aapro, Silvio Monfardini, Antonio Jirillo, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
A double-blind crossover study comparing prophylactic intravenous granisetron alone or in combination with dexamethasone as antiemetic treatment in controlling nausea and vomiting associated with chemotherapyV Kirchner, M Aapro, J P Terrey, et al.
British Journal of Cancer|December 10, 2009
Epoetin-beta treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic eventsM Aapro, B Osterwalder, A Scherhag, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Docetaxel in advanced ovarian cancer: preliminary results from three phase II trials. EORTC Early Clinical Trials Group and Clinical Screening Group, and the MD Anderson Cancer CenterS B Kaye, M Piccart, M Aapro, et al.
AJR. American Journal of Roentgenology|September 1, 1982
Potential pitfall in CT and sonographic evaluation of suspected lymphomaL Creed, K Reger, G D Pond, et al.
Lancet (London, England)|October 31, 1992
Who should receive a 5-HT3 antagonist?S B Kaye, D Khayat, M Aapro, et al.
Revue Medicale Suisse|June 20, 2014
[Together, towards precise oncology!]G Coukos, O Michielin, P- Y Dietrich, et al.
The Journal of Nutrition, Health & Aging|January 20, 2009
Frail old patients as a target population for cancer trialsJ-P Michel, S Pautex, M Aapro, et al.
Cancer Treatment Reviews|February 2, 2016
Taxanes in the treatment of breast cancer: Have we better defined their role in older patients? A position paper from a SIOG Task ForceL Biganzoli, M Aapro, Sibylle Loibl, et al.
Pageof 14

Showing results (31-40 of 138) with videos related to

Sort By:
Pageof 14
Critical Reviews in Oncology/Hematology|May 8, 1998
Screening and chemopreventionL Repetto, C Granetto, A Venturino, et al.
Cancer Treatment Reviews|September 19, 2009
Management of primary and advanced breast cancer in older unfit patients (medical treatment)M Aapro, Silvio Monfardini, Antonio Jirillo, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
A double-blind crossover study comparing prophylactic intravenous granisetron alone or in combination with dexamethasone as antiemetic treatment in controlling nausea and vomiting associated with chemotherapyV Kirchner, M Aapro, J P Terrey, et al.
British Journal of Cancer|December 10, 2009
Epoetin-beta treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic eventsM Aapro, B Osterwalder, A Scherhag, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Docetaxel in advanced ovarian cancer: preliminary results from three phase II trials. EORTC Early Clinical Trials Group and Clinical Screening Group, and the MD Anderson Cancer CenterS B Kaye, M Piccart, M Aapro, et al.
AJR. American Journal of Roentgenology|September 1, 1982
Potential pitfall in CT and sonographic evaluation of suspected lymphomaL Creed, K Reger, G D Pond, et al.
Lancet (London, England)|October 31, 1992
Who should receive a 5-HT3 antagonist?S B Kaye, D Khayat, M Aapro, et al.
Revue Medicale Suisse|June 20, 2014
[Together, towards precise oncology!]G Coukos, O Michielin, P- Y Dietrich, et al.
The Journal of Nutrition, Health & Aging|January 20, 2009
Frail old patients as a target population for cancer trialsJ-P Michel, S Pautex, M Aapro, et al.
Cancer Treatment Reviews|February 2, 2016
Taxanes in the treatment of breast cancer: Have we better defined their role in older patients? A position paper from a SIOG Task ForceL Biganzoli, M Aapro, Sibylle Loibl, et al.
Pageof 14